Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Chemotherapy Treatment on Metaboreflex, Mechanoreflex, and Baroreflex Function: PROTECT-08B Study

NCT07069790 is registered in ClinicalTrials.gov with Centre Paul Strauss as lead sponsor.

NCT NCT07069790
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07069790 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Chemotherapy Treatment on Metaboreflex, Mechanoreflex, and Baroreflex Function: PROTECT-08B Study
Lead sponsor
Centre Paul Strauss
Phase
Not applicable
Overall status
Recruiting
Start date
October 2, 2025
Completion date
October 2, 2026
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast adenocarcinoma